Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice

V Bhaskar, J Yin, AM Mirza, D Phan, S Vanegas… - Atherosclerosis, 2011 - Elsevier
OBJECTIVE: Atherosclerosis is a condition that is increasingly contributing to worldwide
mortality through complications such as stroke and myocardial infarction. IL-1β plays …
被引用次数：273 相关文章

Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice

V Bhaskar, J Yin, AM Mirza, D Phan… - …, 2011 - pubmed.ncbi.nlm.nih.gov
Objective Atherosclerosis is a condition that is increasingly contributing to worldwide
mortality through complications such as stroke and myocardial infarction. IL-1β plays …

Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice

V Bhaskar, J Yin, AM Mirza, D Phan, S Vanegas… - Atherosclerosis, 2011 - infona.pl
Atherosclerosis is a condition that is increasingly contributing to worldwide mortality through
complications such as stroke and myocardial infarction. IL-1β plays multiple direct, local …
[PDF] academia.edu

[PDF][PDF] Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient …

V Bhaskar, J Yin, AM Mirza, D Phan, S Vanegas… - …, 2011 - academia.edu
abstract Objective: Atherosclerosis is a condition that is increasingly contributing to
worldwide mortality through complications such as stroke and myocardial infarction. IL-1 …

Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice

V Bhaskar, J Yin, AM Mirza, D Phan… - …, 2011 - atherosclerosis-journal.com
Objective Atherosclerosis is a condition that is increasingly contributing to worldwide
mortality through complications such as stroke and myocardial infarction. IL-1β plays …

Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice.

V Bhaskar, J Yin, AM Mirza, D Phan, S Vanegas… - …, 2011 - europepmc.org
Objective Atherosclerosis is a condition that is increasingly contributing to worldwide
mortality through complications such as stroke and myocardial infarction. IL-1β plays …

[引用][C] Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient …

V BHASKAR, J YIN, AM MIRZA, D PHAN… - …, 2011 - pascal-francis.inist.fr
Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and
inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice CNRS Inist Pascal-Francis …

[引用][C] Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient …

V BHASKAR, J YIN, AM MIRZA, D PHAN, S VANEGAS… - Atherosclerosis, 2011 - Elsevier